Monforte AM - Search Results

1

Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents.

Rao A, Balzarini J, Carbone A, Chimirri A, De Clercq E, Monforte AM, Monforte P, Pannecouque C, Zappalà M. Rao A, et al. Among authors: monforte am, monforte p. Farmaco. 2004 Jan;59(1):33-9. doi: 10.1016/j.farmac.2003.09.001. Farmaco. 2004. PMID: 14751314

2

Anti-HIV agents: design and discovery of new potent RT inhibitors.

Barreca ML, Chimirri A, De Clercq E, De Luca L, Monforte AM, Monforte P, Rao A, Zappalà M. Barreca ML, et al. Among authors: monforte am, monforte p. Farmaco. 2003 Mar;58(3):259-63. doi: 10.1016/S0014-827X(03)00024-7. Farmaco. 2003. PMID: 12620421 Review.

3

Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.

Barreca ML, Rao A, De Luca L, Zappalà M, Monforte AM, Maga G, Pannecouque C, Balzarini J, De Clercq E, Chimirri A, Monforte P. Barreca ML, et al. Among authors: monforte am, monforte p. J Med Chem. 2005 May 5;48(9):3433-7. doi: 10.1021/jm049279a. J Med Chem. 2005. PMID: 15857150

4

Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains.

Barreca ML, Rao A, De Luca L, Iraci N, Monforte AM, Maga G, De Clercq E, Pannecouque C, Balzarini J, Chimirri A. Barreca ML, et al. Among authors: monforte am. Bioorg Med Chem Lett. 2007 Apr 1;17(7):1956-60. doi: 10.1016/j.bmcl.2007.01.025. Epub 2007 Jan 19. Bioorg Med Chem Lett. 2007. PMID: 17276064

5

Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors.

Monforte AM, Rao A, Logoteta P, Ferro S, De Luca L, Barreca ML, Iraci N, Maga G, De Clercq E, Pannecouque C, Chimirri A. Monforte AM, et al. Bioorg Med Chem. 2008 Aug 1;16(15):7429-35. doi: 10.1016/j.bmc.2008.06.012. Epub 2008 Jun 13. Bioorg Med Chem. 2008. PMID: 18585918

6

Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.

Monforte AM, Logoteta P, Ferro S, De Luca L, Iraci N, Maga G, Clercq ED, Pannecouque C, Chimirri A. Monforte AM, et al. Bioorg Med Chem. 2009 Aug 15;17(16):5962-7. doi: 10.1016/j.bmc.2009.06.068. Epub 2009 Jul 3. Bioorg Med Chem. 2009. PMID: 19616956

7

Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Monforte AM, Logoteta P, De Luca L, Iraci N, Ferro S, Maga G, De Clercq E, Pannecouque C, Chimirri A. Monforte AM, et al. Bioorg Med Chem. 2010 Feb 15;18(4):1702-10. doi: 10.1016/j.bmc.2009.12.059. Epub 2010 Jan 4. Bioorg Med Chem. 2010. PMID: 20097079

8

Design and synthesis of N₁-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.

Monforte AM, Ferro S, De Luca L, Lo Surdo G, Morreale F, Pannecouque C, Balzarini J, Chimirri A. Monforte AM, et al. Bioorg Med Chem. 2014 Feb 15;22(4):1459-67. doi: 10.1016/j.bmc.2013.12.045. Epub 2013 Dec 30. Bioorg Med Chem. 2014. PMID: 24457088

9

Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-(thi)one derivatives.

Rao A, Carbone A, Chimirri A, De Clercq E, Monforte AM, Monforte P, Pannecouque C, Zappalà M. Rao A, et al. Among authors: monforte am, monforte p. Farmaco. 2002 Sep;57(9):747-51. doi: 10.1016/s0014-827x(02)01268-5. Farmaco. 2002. PMID: 12385525

10

Synthesis and anti-hIV activity of 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2-substituted benzimidazoles.

Rao A, Chimirri A, De Clercq E, Monforte AM, Monforte P, Pannecouque C, Zappalà M. Rao A, et al. Among authors: monforte am, monforte p. Farmaco. 2002 Oct;57(10):819-23. doi: 10.1016/s0014-827x(02)01300-9. Farmaco. 2002. PMID: 12420877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page